Skip to main content

FoG Boston 

REGISTER

FoG Boston 

REGISTER

2025 Agenda

Image

2025 Agenda

Loading
Search Filters
  • Location
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
Innovation Stage
  1. At The Forefront of Genomics: Making Genomic Medicine a Reality
    Innovation Stage
    Eric Green
    Eric Green, Former Director - NHGRI
  2. PANEL: How Is the Genomics Ecosystem Responding to the Current Climate?
    Innovation Stage
    Robert Green
    Robert Green, Professor of Medicine (Genetics) - Harvard Medical School 
    Eric Green
    Eric Green, Former Director - NHGRI
    Anthony Monaco
    Anthony Monaco, University Professor and President emeritus - Tufts University
    Stacey Gabriel
    Stacey Gabriel, Executive Vice President of Platforms and Scientific Execution - Broad Institute
  3. From algorithms to advancing care: genomics data drives progress
    Innovation Stage
    Jack DiGiovanna
    Jack DiGiovanna, Chief Scientific Officer - Velsera
  4. Fireside Chat: From Sequencing to Sailing - A Journey of Genomics
    Innovation Stage
    J. Craig Venter
    J. Craig Venter, Founder, Chairman, and CEO - J. Craig Venter Institute  
  5. Networking Break
    Innovation Stage
  6. PANEL: Sequencing in 2025 and Beyond
    Innovation Stage
    Niall Lennon
    Niall Lennon, Senior Director, Genomics Platform - Broad Institute of MIT and Harvard
    Claire Hartmann
    Claire Hartmann, Director of the Bauer Core - Harvard   
    Bony Kumar
    Bony Kumar, Director of Operations - Yale Genome Analysis Center
  7. Sequencing by Expansion (SBX), a versatile, high-throughput single-molecule sequencing technology for a variety of applications
    Innovation Stage
    Mark Kokoris
    Mark Kokoris, Vice President, Head of SBX Technology - Roche Diagnostics
  8. Reliable Detection of DNA Modifications Using Long Read Sequencing
    Innovation Stage
    Gang Fang
    Gang Fang, Professor - Mount Sinai
  9. Accelerating Genomic Discovery Via High-Throughput Workflows
    Innovation Stage
    John Fuller
    John Fuller, Commercial Product Manager - Beckman Coulter Life Sciences
  10. Mapping Cancer Resistance with High-Resolution Spatial Transcriptomics
    Innovation Stage
    Oriol Llorà Batlle
    Oriol Llorà Batlle, Team Lead R&D - Single Cell Discoveries
  11. Removing the Barriers of Automating Plasmid DNA Extractions
    Innovation Stage
    Brandon Easparro
    Brandon Easparro, Product Manager - Omega Bio-tek
  12. A new class of single-cell spatial multiomics
    Innovation Stage
  13. Exploration of Transcriptome Diversity Using Long-Read Sequencing
    Innovation Stage
    Daniel Le
    Daniel Le, Principal Bioinformatics Scientist - Genentech
  14. Epigenomic and fragmentomic analysis of cell-free DNA in cancer with Oxford Nanopore sequencing
    Innovation Stage
    Billy Lau
    Billy Lau, Instructor - Stanford University School of Medicine
  15. Long-Read Sequencing for Brain Tumours
    Innovation Stage
    Analiz Rodriguez
    Analiz Rodriguez, Director of Neurosurgical Oncology - UAMS
  16. Networking Break
    Innovation Stage
  17. Long-Read Sequencing as A One-Stop-Test for Rural Rare Disease
    Innovation Stage
    Ana Cohen
    Ana Cohen, Assistant Director - Children's Mercy Kansas City Genomic Medicine Center
  18. Quantifying Rare: A Data-Driven Approach to Monogenic Disorder Prevalence
    Innovation Stage
    Sun-Gou Ji
    Sun-Gou Ji, Vice President, Head of Computational Genetics - BridgeBio
    Mahmoud Husseini
    Mahmoud Husseini, VP, Head of Biopharma Partnerships - GeneDx
  19. Revealing Complex Genotype-Phenotype Correlations using Population-Scale Long-Read Sequencing
    Innovation Stage
    Fritz Sedlazeck
    Fritz Sedlazeck, Associate Professor - Baylor College of Medicine 
AI in Drug Discovery Stage
  1. Leveraging Advanced AI/ML to Accelerate Drug Discovery: from Target Identification to Disease Indication and Patient Stratification
    AI in Drug Discovery Stage
    Emanuele de Rinaldis
    Emanuele de Rinaldis, Global Head of Target Disease & Systems Biology - Sanofi
  2. Polly Co-Scientist: Accelerating Disease Mechanism Discovery with AI-powered Knowledge Graphs
    AI in Drug Discovery Stage
    Abhishek Jha
    Abhishek Jha, CEO - Elucidata
  3. Target Identification and Validation with One Research FAIR Data Lakes
    AI in Drug Discovery Stage
    Marcin von Grotthuss
    Marcin von Grotthuss, Director, Data Integration - Takeda
  4. Lunch Break
    AI in Drug Discovery Stage
  5. The Promise of AI/ML for Preclinical Drug Discovery
    AI in Drug Discovery Stage
    Brandon Probst
    Brandon Probst, Vice President, Biology - Recursion
  6. AI at GSK: a grand challenge and some practical results
    AI in Drug Discovery Stage
    Ching- Hao Wang
    Ching- Hao Wang, Director of AI/ML Engineering - GSK
  7. PANEL: Empowering Your AI Applications in Therapeutic Target Discovery
    AI in Drug Discovery Stage
    Manoj Kandpal
    Manoj Kandpal, Director of Research Bioinformatics, Center for Clinical and Translational Science - The Rockefeller University
    Michael Steinbaugh
    Michael Steinbaugh, Director, Data, AI & Genome Sciences - Merck
    Shameer Khader
    Shameer Khader, Executive Director - Precision Medicine and Computational Biology - Sanofi
    Simona Cristea
    Simona Cristea, Head of Genomics and AI - Dana-Farber Cancer Institute
    Bissan Al-Lazikani
    Bissan Al-Lazikani, Director of Therapeutics Data Science and Professor of Genomic Medicine - The University of Texas MD Anderson Cancer Center
  8. Networking Break
    AI in Drug Discovery Stage
  9. Practical DMTA: Effective lead optimization of biologics drug candidates
    AI in Drug Discovery Stage
    Anshul Kanakia
    Anshul Kanakia, Director, Data Science - AstraZeneca
  10. Redefining Precision Oncology with an End-to-End AI Platform for Drug Development
    AI in Drug Discovery Stage
    Mike Goldberg
    Mike Goldberg, Vice President, R&D - BostonGene
  11. Utilizing Foundation Models to Evaluate Immunotherapy Resistance Mechanisms in Cancer
    AI in Drug Discovery Stage
    Gaurav Kumar
    Gaurav Kumar, Associate Director, Computational Biology - Teva Pharmaceuticals 
Biodata Stage
  1. PANEL: Scaling Big Genomics Data to Support Drug Development Strategy
    Biodata Stage
    Violet Zhang
    Violet Zhang, Associate Director - GSK
    Huilei Xu
    Huilei Xu, Associate Director, Data Science - Novartis
    Yupu Liang
    Yupu Liang, Head of Bioinformatics Data Engineering - Alexion Pharmaceuticals
  2. A modern data & compute solution for biological R&D
    Biodata Stage
    Kyle Giffin
    Kyle Giffin,  Chief Operating Officer - LatchBio
  3. Using Million Veteran Program Data to Improve Health Care in the Healthcare of Veterans
    Biodata Stage
    Jason Vassy
    Jason Vassy, Associate Professor and Director - Genomes2Veterans Research Program, Harvard Medical School
  4. Lunch Break
    Biodata Stage
  5. Large Scale Population Genetics Influencing Common & Rare Disease Drug Discovery
    Biodata Stage
    Guillermo del Angel
    Guillermo del Angel, Executive Director, Rare Diseases Head, Centre for Genomics Research - AstraZeneca
  6. How a Cloud-Based Omics Data Catalog Streamlines Research at Revolution Medicines
    Biodata Stage
    Yevgeniy Gindin
    Yevgeniy Gindin, Executive Director of Bioinformatics - Revolution Medicines
    Ankit Malhotra
    Ankit Malhotra, Head of Genomics - Strategy and Solutions, AWS Healthcare & Life Sciences
  7. Advancing the Landscape of Clinical Actionability in Cancer: An Evidence-based Framework from the INT²GRATE Oncology Consortium
    Biodata Stage
    Arezou Ghazani
    Arezou Ghazani, Director, Clinical Genomics - Brigham and Women’s Hospital
  8. Networking Break
    Biodata Stage
  9. Harnessing Multi-Omic Cancer Data with the Genomic Data Commons (GDC): An Impactful Discovery Tool for Cancer Progression and Response to Therapy
    Biodata Stage
    David Sturgill
    David Sturgill, Project Officer, Genomic Data Commons - NCI
  10. Beyond the Lake: A Federated Data Platform for BioData
    Biodata Stage
    Karl Gutwin
    Karl Gutwin, Principal Consultant - BioTeam LLC
  11. Advancing Alzheimer's Research through Genomics: Insights from ADSP and NIAGADS
    Biodata Stage
    Li-San Wang
    Li-San Wang, Co-Director Penn Neurodegeneration Genomics Center - University of Pennsylvania 
Cancer Diagnostics Stage
  1. Leveraging a Multi-Omic Approach to Liquid Biopsy Cancer Detection and Profiling
    Cancer Diagnostics Stage
    Aadel Chaudhuri
    Aadel Chaudhuri, Vice Chair for Translational Research - Mayo Clinic
  2. Embracing the power of liquid biopsy through genome-wide methylation profiling
    Cancer Diagnostics Stage
    Chennan Li
    Chennan Li, Postdoctoral Fellow - National Cancer Institute
  3. Applications of Liquid Biopsy in Drug Development
    Cancer Diagnostics Stage
    Victoria Rimkunas
    Victoria Rimkunas, Vice President, Translational Medicine - Repare Therapeutics
  4. Lunch Break
    Cancer Diagnostics Stage
  5. Discovering cfDNA methylation biomarkers for liquid biopsy-based cancer detection
    Cancer Diagnostics Stage
    Bodour Salhia
    Bodour Salhia, Inaugural Interim Chair of Cancer Biology - University of Southern California
  6. Modulating the Biology of cfDNA to Improve Liquid Biopsies
    Cancer Diagnostics Stage
    Viktor Adalsteinsson
    Viktor Adalsteinsson, Director of the Gerstner Center for Cancer Diagnostics - The Broad Institute of MIT and Harvard
  7. Networking Break
    Cancer Diagnostics Stage
  8. Foundation models for learning cancer progression and drug response
    Cancer Diagnostics Stage
    Simona Cristea
    Simona Cristea, Head of Genomics and AI - Dana-Farber Cancer Institute
  9. Integrating Data to Uncover Molecular Mechanisms of Cancer Development and Genotype-Phenotype Insights
    Cancer Diagnostics Stage
    Irina Pushel
    Irina Pushel, Bioinformatics Manager - Children’s Mercy Research Institute 
  10. Advancing Precision Medicine in Breast Cancer: Targeting Resistance Mechanisms and Metastasis
    Cancer Diagnostics Stage
    Adrian Lee
    Adrian Lee, Director - Institute of Precision Medicine, UPMC
Multi-Omics Stage
  1. How to Effectively Integrate Multi-Omic Data to Model Gene Regulatory Networks
    Multi-Omics Stage
    Kimberly Glass
    Kimberly Glass, Assistant Professor - Brigham and Women's Hospital and Harvard Medical School
  2. Harnessing the Power of Multiomics Characterization from a Single Sample
    Multi-Omics Stage
    Katie Duval
    Katie Duval, Technical Application Scientist - Genewiz
  3. HIP: A Method for High-Dimensional Multi-View Omic Data Integration and Prediction Accounting for Subgroup Heterogeneity
    Multi-Omics Stage
    Sandra Safo
    Sandra Safo, Associate Professor - University of Minnesota
  4. Lunch Break
    Multi-Omics Stage
  5. How to Use Directional Multi-Omics Data Fusion for Gene Prioritization and Pathway Enrichment Analysis
    Multi-Omics Stage
    Jüri Reimand
    Jüri Reimand, Prinicple Investigator - University of Toronto
  6. From samples to insights: Real-world applications of multiomics for understanding biology and advancing human health
    Multi-Omics Stage
    Harsha Gowda
    Harsha Gowda, Sr. Principal Scientist & Director of Research & Lab Ops - Signios Bio
  7. How to Apply Novel Multi-Omic Genomic Techniques to Study Aging and Aging-Related Diseases
    Multi-Omics Stage
    Junyue Cao
    Junyue Cao, Assistant Professor - The Rockefeller University
  8. Networking Break
    Multi-Omics Stage
  9. Multi-Omics and AI Network-Based Strategies for Therapeutic Discovery
    Multi-Omics Stage
    Azam Yazdani
    Azam Yazdani, Assistant Professor - Harvard University
  10. DRUG-seq: high throughput extraction-free transcriptomics for next-generation compound screening
    Multi-Omics Stage
    Andrea Hadjikyriacou
    Andrea Hadjikyriacou, Account Executive - Alithea Genomics
    Robert Ihry
    Robert Ihry, Senior Principal Scientist - Novartis Biomedical Research
  11. Driving Clinical Decisions with AI and Integrated Omic
    Multi-Omics Stage
    Vinayagam Arunachalam
    Vinayagam Arunachalam, Senior Director, Head of Computational and Systems Biology - Takeda
Proteomics Stage
  1. PANEL: Proteomics at Scale: Big Studies, Big Data and Even Bigger Opportunities
    Proteomics Stage
    Benjamin Sun
    Benjamin Sun, Director and Head of Population Health Omics - Bristol Myers Squibb
    Melissa Miller
    Melissa Miller, Senior Director of Human Genetics - Pfizer
    Sonja Hess
    Sonja Hess, Senior Director, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D - AstraZeneca
  2. Precision Proteomics: Advancing Drug Development with Next-Gen Protein Sequencing
    Proteomics Stage
    Meredith Carpenter
    Meredith Carpenter, Head of Scientific Affairs - Quantum-Si
    Melissa Deck
    Melissa Deck, Director of Platform - Liberate Bio
  3. Mass Spectrometry-based Proteomics: From Single Cells to Clinical Applications
    Proteomics Stage
    Judith Steen
    Judith Steen, Director of Neuroproteomics - Boston Children's Hospital
  4. Lunch Break
    Proteomics Stage
  5. Using High-Throughput Affinity Proteomics to Develop a Proteomic Aging Clock
    Proteomics Stage
    Breno Salter Diniz
    Breno Salter Diniz, Associate Professor - University of Connecticut 
  6. From Pilots to Breakthroughs: How Proteomics is revealing the truth of human biology, transforming our approach to disease prediction, progression and our approach to pharma intervention
    Proteomics Stage
    Cindy Lawley
    Cindy Lawley, Sr. Director, Population Health - Olink Proteomics
  7. Proteogenomic Analysis of Human Colon To Identify Druggabe Targets
    Proteomics Stage
    Suhas Vasaikar
    Suhas Vasaikar, Associate Director - Pfizer
  8. Networking Break
    Proteomics Stage
  9. Finding Actionable Therapeutic Vulnerabilities in Breast Cancer Using Proteogenomics
    Proteomics Stage
    Julie Lang
    Julie Lang, Chief of Breast Surgery, Hillcrest Hospital & Director, Eastern Region Breast Program - Cleveland Clinic
  10. Using Integrative Proteogenomic Analysis to Identify New Targets and Risk Factors for Cardiometabolic Diseases
    Proteomics Stage
    Satoshi Yoshiji
    Satoshi Yoshiji, Assistant Professor - McGill University
  11. Computational methods for large-scale proteogenomic data analysis
    Proteomics Stage
    DR Mani
    DR Mani, Director of Computational Proteomics - Broad Institute
Single-Cell and Spatial
  1. Identifying Novel Targetable Pathways/Biology with Single Cell Atlases
    Single-Cell and Spatial
    Saurabh Vishnu Laddha
    Saurabh Vishnu Laddha, Principal Computational Scientist - Johnson & Johnson Innovative Medicines
  2. Redefining Single Cell RNA Sequencing Limits with Evercode™ Combinatorial Barcoding
    Single-Cell and Spatial
    Charlie Roco
    Charlie Roco, CTO and Co-Founder - Parse Biosciences
  3. How to Repurpose Drugs using Single-Cell and Spatial Transcriptomics Data
    Single-Cell and Spatial
    Lana Garmire
    Lana Garmire, Associate Professor - University of Michigan
  4. Lunch Break
    Single-Cell and Spatial
  5. Single-Cell Sequencing to Evaluate a Novel PTPN1/2 Inhibitor Driving Antitumor Immunity
    Single-Cell and Spatial
    Kyle Halliwill
    Kyle Halliwill, Group Lead, Oncology Bioinformatics, Immuno-oncology - AbbVie Biotherapeutics
  6. Charting Tumor Microenvironment Interactions with Arrayed scRNA-seq Screens in Patient Co-Cultures
    Single-Cell and Spatial
    Sam Cooper
    Sam Cooper, Chief Technical Officer, Phenomic - Scale Biosciences
  7. Map Genetic and Non-Genetic Disease Drivers through Single-Cell Multi-Omics
    Single-Cell and Spatial
    Anna S. Nam
    Anna S. Nam, Assistant Professor - Weill Cornell Medicine and New York Presbyterian Hospital
  8. Networking Break
    Single-Cell and Spatial
  9. Harnessing MultiTME: Multi-Sample, Multimodal Spatial to Model the Tumor Microenvironment
    Single-Cell and Spatial
    Wesley Tansey
    Wesley Tansey, Principal Investigator and Assistant Attending Computational Oncologist - Memorial Sloan Kettering Cancer Centre
  10. A Scalable Platform for Simultaneous Single-Cell Imaging and Sequencing
    Single-Cell and Spatial
    Caroline Sartain
    Caroline Sartain, Director of Assay Development & Applications - Flexomics
  11. Identifying lung cancer patient treatment stratification using single-cell and spatial genomics
    Single-Cell and Spatial
    Alexander Tsankov
    Alexander Tsankov, Associate Professor, Genetics and Genomic Sciences - Ichan School of Medicine at Mount Sinai
Genome Dome
  1. Roundtable Discussion: Building Inclusivity and Trust in Genomics
    Genome Dome
    Angélica Torres-Berrío
    Angélica Torres-Berrío, Director of the Social and Cognitive Research - Lurie Center for Autism, Massachusetts General Hospital
    Maria Chahrour
    Maria Chahrour, Associate Professor - University of Texas Southwestern Medical Center
    Anna Lewis
    Anna Lewis, Research Scientist and Associate - Harvard Medical School and Brigham and Women's Hospital
  2. Lunch Break
    Genome Dome
  3. Roundtable Discussion: AI in Healthcare Transformation
    Genome Dome
    David Bates
    David Bates, Professor of Medicine - Harvard Medical School 
    Jason Johnson
    Jason Johnson, Senior Vice President, Chief Data and Analytics Officer - Dana-Farber Cancer Institute
  4. Networking Break
    Genome Dome
  5. Roundtable Discussion: Transforming Diagnosis in the Digital Age: Digital Pathology & AI
    Genome Dome
    Uma Saxena
    Uma Saxena, Digital Pathology, Computational Biology - Bristol Myers Squibb
    Orr Ashenberg
    Orr Ashenberg, Associate Director, Computational Biology - Broad Institute of MIT and Harvard
    Qing Li
    Qing Li, Director - Moderna
Room 50
  1. Workshop: Mastering Spatial Data Analysis: From Basics to Cutting-Edge Innovations
    Room 50
    Abul Hassan Samee
    Abul Hassan Samee, Associate Professor, Integrative Physiology - Baylor College of Medicine 
    Ilya Korsunsky
    Ilya Korsunsky, Principal Investigator - Brigham and Women’s Hospital
  2. Lunch Break
    Room 50
  3. Workshop: Computational Biology Upskilling
    Room 50
    Tommy Tang
    Tommy Tang, Director of Bioinformatics - AstraZeneca
    Dean Lee
    Dean Lee, Senior Expert I, Data Science - Novartis
  4. Roundtable: Sustaining Innovation: Rethinking Genomics Funding for the Long Haul
    Room 50
    Chandana Haque
    Chandana Haque, Executive Director - Altitude Lab 
    Niall Lennon
    Niall Lennon, Senior Director, Genomics Platform - Broad Institute of MIT and Harvard
    Miten Jain
    Miten Jain, Assistant Professor - Northeastern University
  1. More details to be announced shortly
Innovation Stage
  1. Catching the Floating DNA Around Us
    Innovation Stage
    Carl Zimmer
    Carl Zimmer, Columnist and Author - New York Times
  2. The Power of Preventative Genomic Screening
    Innovation Stage
    Robert Green
    Robert Green, Professor of Medicine (Genetics) - Harvard Medical School 
  3. How Generative AI is transforming Biology, Genomic Medicine and Therapeutic Development
    Innovation Stage
    Manolis Kellis
    Manolis Kellis, Professor of Computer Science - MIT
  4. Unlocking data, unlocking treatments: AI in ALS
    Innovation Stage
    Caroline Purslow
    Caroline Purslow, Head of Health - Challenge Works
    Pat Brannelly
    Pat Brannelly, CEO - 10'000 Brains Project
  5. Using Advanced Molecular Diagnostics to Improve Risk-Aligned Patient Care and Outcomes
    Innovation Stage
    Matthew Goldberg
    Matthew Goldberg, M.D., FAAD, Senior Vice President, Medical - Castle Biosciences
  6. Panel: Reimagining Healthcare by bridging the gap between Innovation and Patient Impact
    Innovation Stage
    Nicole Renaud
    Nicole Renaud, Director - Global Co-Lead of Human Genetics & Targets, Discovery Sciences - Novartis
    Jeffrey Reid
    Jeffrey Reid, Vice President, RGC Chief Data Officer - Regeneron
    Joseph Maranville
    Joseph Maranville, Executive Director - Bristol Myers Squibb
    Melissa Miller
    Melissa Miller, Senior Director of Human Genetics - Pfizer
  7. Networking Break
    Innovation Stage
  8. Epigenetic Biomarkers of Phenotypic traits and Environmental Signatures
    Innovation Stage
    Andres Cardenas
    Andres Cardenas, Assistant Professor - Stanford University
  9. Decoding Prenatal Smoke Exposure: An Integrative Omics Approach to Lung Health and Precision Medicine
    Innovation Stage
    Priyadarshini Kachroo
    Priyadarshini Kachroo, Assistant Professor, Department of Health Informatics - Rutgers University School
  10. Harnessing Epigenetics to Combat Chemoresistant Cancer Cells
    Innovation Stage
    Noha Shendy
    Noha Shendy, Postdoctoral Research Fellow - St. Jude Children Research Hospital
  11. Networking Break
    Innovation Stage
  12. Serial cell-free DNA sequencing revealed genomic signatures associated with prostate cancer progression
    Innovation Stage
    Samira Rahimirad
    Samira Rahimirad, PhD student - McGill University Health Centre
  13. Recurrent Somatic scSNVs in Single-Cell RNA-Seq: Insights into Tumor Heterogeneity and RNA-Level Variants
    Innovation Stage
    Hovhannes Arestakesyan
    Hovhannes Arestakesyan, Bioinformatics Specialist - The George Washington University
  14. Linking Rare Non-Coding Regulatory Variants Associated with Human Longevity to Cellular Senescence via Integrative Functional Genomic Approaches
    Innovation Stage
    Jiping Yang
    Jiping Yang, Associate Research Scientist - Columbia University Medical Center
  15. Multiomics analysis of weight loss in a Mediterranean cohort that has undergone a lifestyle intervention
    Innovation Stage
    Dolores Corella
    Dolores Corella, Prof. Preventive Medicine and Genomics - University of Valencia
  16. Advancing the Human Genomics of Infectious Diseases through Whole Genome Sequencing and Diverse Biobanks
    Innovation Stage
    Samira Asgari
    Samira Asgari, Assistant Professor of Genetics and Genomic Sciences at the Institute for Genomic Health - Icahn School of Medicine at Mount Sinai
  17. Applying Molecular Genetics and Cytogenetics in the Clinic for Variant Reporting
    Innovation Stage
    Heather Mason-Suares
    Heather Mason-Suares, Associate Professor in Pathology - Brigham and Women's Hospital   
  18. Assessing Genome Integrity of Gene Therapy Vectors Using Long-Read (SMRT) Sequencing
    Innovation Stage
    Prasad Kesanakurti
    Prasad Kesanakurti, NGS Scientist - Sanofi
  19. A Fireside Chat - More details to be announced shortly
    Innovation Stage
    George Church
    George Church, Professor of Genetics - Harvard Medical School & MIT
AI in Drug Discovery Stage
  1. Genomics, Stem Cells, and AI for Drug Discovery
    AI in Drug Discovery Stage
    Joseph Wu
    Joseph Wu, Director, Stanford Cardiovascular Institute - Stanford University
  2. Creating A Transcriptomic Atlas of Drug Responses in Primary Human Cells
    AI in Drug Discovery Stage
    Ayla Ergun
    Ayla Ergun, Senior Director of Data Science - Ginkgo Bioworks
  3. Phenomic Foundation Models for Drug Discovery
    AI in Drug Discovery Stage
    Safiye Celik
    Safiye Celik, Associate Director, Data Science - Recursion
  4. Lunch Break
    AI in Drug Discovery Stage
  5. Accelerating Genomic Data Science through Composable AI/ML Bioinformatics
    AI in Drug Discovery Stage
    Nezar Abdennur
    Nezar Abdennur, Assistant Professor of Genomics and Computational Biology - UMass Chan Medical School
  6. AI/ML Algorithms for Disease Subtyping and Patient Stratification Toward Personalized Medicine
    AI in Drug Discovery Stage
    Akram Yazdani
    Akram Yazdani, Assistant Professor - The University of Texas Health Science Center
  7. PANEL: How to Optimize Data Strategies & Trends to Improve AI for Drug Discovery?
    AI in Drug Discovery Stage
    Elena Dolgikh
    Elena Dolgikh, Head of Computational Chemistry/AI/ML - Monte Rosa Therapeutics
    Emanuele de Rinaldis
    Emanuele de Rinaldis, Global Head of Target Disease & Systems Biology - Sanofi
    Rohit Arora
    Rohit Arora, Innovation Lead - Novo Nordisk Bio Innovation Hub
    Charles O'Donnell
    Charles O'Donnell, Vice President, Head of Computational Genomics and Data Sciences - Omega Therapeutics
Biodata Stage
  1. Multi-modal data platform to analyze APOLLOE4 Phase 3 study in APOE4/4 homozygotes with early Alzheimer’s
    Biodata Stage
    Adem Albayrak
    Adem Albayrak, Chief Data Officer - Alzheon
  2. Illuminating Disease & Drug Landscapes : Unravelling Data & Insights
    Biodata Stage
    Jitesh Kannan Pillai
    Jitesh Kannan Pillai, Group Head, Program Management Bioinformatics - Excelra
    Ying-Wooi Wan
    Ying-Wooi Wan, Senior Scientist Computational Biology, GI2-TAU Early Clinical Development - Takeda
  3. Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery
    Biodata Stage
    Chao Fang
    Chao Fang, Associate Director, Oncology Data Science - AstraZeneca
  4. Lunch Break
    Biodata Stage
  5. Harnessing Population-Scale Biodata: Leveraging Data from the All of Us Researcher Workbench and BCM's IMAGINE Program for Precision Health
    Biodata Stage
    Eric Venner
    Eric Venner, Director of Clinical Informatics, Human Genome Sequencing Center - Baylor College of Medicine 
  6. Big Data to Improve Prostate Outcomes: The Genetics of Prostate Cancer and Survival
    Biodata Stage
    Robert Klein
    Robert Klein, Associate Professor, Genetics and Genomic Sciences - Icahn School of Medicine at Mount Sinai
  7. Automated Real-World Data Integration Improves Cancer Outcome Prediction
    Biodata Stage
    Nikolaus Schultz
    Nikolaus Schultz, Director, Cancer Data Science Initiative - Memorial Sloan Kettering Cancer Center   
Cancer Diagnostics Stage
  1. PANEL: Paving the Way Towards Liquid First. Challenges, Opportunities and Reality
    Cancer Diagnostics Stage
    Lauren Leiman
    Lauren Leiman, Executive Director - Bloodpac
    Raluca Budiu-Predoiu
    Raluca Budiu-Predoiu, Director of Precision Medicine - AbbVie
    Aleksandra Markovets
    Aleksandra Markovets, Director - AstraZeneca
  2. Next-Generation MRD Assays: Do We Have the Tools to Evaluate Them Properly?
    Cancer Diagnostics Stage
    Hugh Russell
    Hugh Russell, Director ctDNA Strategy (Secondment), Clinical Biomarker Development, - AstraZeneca
  3. Multi-omic Analyses of CTCs for Cancer Profiling and Diagnostics
    Cancer Diagnostics Stage
    David Miyamoto
    David Miyamoto, Physician Scientist and Radiation Oncologist - Massachusetts General Hospital
  4. Lunch Break
    Cancer Diagnostics Stage
  5. Studying Extracellular Vesicle-Derived Proteins as Novel Biomarkers for Genitourinary Cancers
    Cancer Diagnostics Stage
    Alex Rai
    Alex Rai, Professor and Director of the Clinical Chemistry Service - Columbia University
  6. Companion Diagnostic Development for TCR-Ts
    Cancer Diagnostics Stage
    Elaine Joseph
    Elaine Joseph, Director of Precision Medicine - AstraZeneca
  7. Using Immunotherapy Earlier to Target a Genetic Mutation: Most Promising Experimental Rectal Cancer Treatment
    Cancer Diagnostics Stage
    Andrea Cercek
    Andrea Cercek, Medical Oncologist, Founder and Co-Director of the Center for Young Onset Colorectal and Gastrointestinal Cancer - Memorial Sloan Kettering Cancer Center   
Multi-Omics Stage
  1. Clinical Proteomics and Metabolomics in Biomarker Discovery
    Multi-Omics Stage
    Sonja Hess
    Sonja Hess, Senior Director, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D - AstraZeneca
  2. High Dimensional Biology: Single Cell & Spatial Multiomics Powered by AVITI24
    Multi-Omics Stage
    Terrence Hanscom
    Terrence Hanscom, Field Applications Scientist - Element Biosciences
    Linda D. Orzolek
    Linda D. Orzolek, Head of Lab Operations - OMAPiX, Inc
  3. The Power of Scaling and Deepening Datasets to Drive Medicines of the Future
    Multi-Omics Stage
    Gonçalo Abecasis
    Gonçalo Abecasis, Vice President and Chief Genomics and Data Science Officer - Regeneron
  4. Lunch Break
    Multi-Omics Stage
  5. Dissecting Tumor–Immune Dynamics in Melanoma Through Multimodal Data Integration
    Multi-Omics Stage
    Giuseppe Tarantino
    Giuseppe Tarantino, Instructor in Medicine, Computational biologist - Harvard Medical School, Dana-Farber Cancer Institute and the Broad Institute
  6. A Multi-Omics Atlas of Human B Cell Activation Reveals Regulatory Mechanisms Underlying Immune Disease Risk
    Multi-Omics Stage
  7. Decipher Responses to Infections using Multi-Scale Multi-Omics Approaches
    Multi-Omics Stage
    Christian Forst
    Christian Forst, Associate Professor in the Department of Genetics and Genomic Sciences - Icahn School of Medicine at Mount Sinai
Proteomics Stage
  1. Supporting Clinical Trials with High-Throughput Proteomic Profiling from Liquid Biopsies
    Proteomics Stage
    Jessica Makofske
    Jessica Makofske, Associate Director - Novartis
  2. Advancing early target discovery through large-scale proteomics and expansion plans for the UKB-PPP
    Proteomics Stage
    Joshua Chiou
    Joshua Chiou, Senior Principal Computational Geneticist - Pfizer
  3. Exploring Organ Crosstalk in a Model for Atherosclerosis using Comprehensive Plasma Proteomics
    Proteomics Stage
    Sasha Singh
    Sasha Singh, Director of Proteomics Research - Brigham and Women’s Hospital
  4. Lunch Break
    Proteomics Stage
  5. Developing a Spatial Analysis Toolbox for Early Drug Discovery using Targeted Proteomics and Transcriptomics
    Proteomics Stage
    Vineeth Raghuram
    Vineeth Raghuram, Senior Scientist I - AbbVie
  6. Multimodal Imaging Methods for Understanding Complex Biological Phenomena
    Proteomics Stage
    Elizabeth Neumann
    Elizabeth Neumann, Assistant Professor - UC Davis
  7. Spatial Proteotranscriptomic Integration to Reveal Therapeutic Resistance Mechanisms in Cancer
    Proteomics Stage
    Martin Hemberg
    Martin Hemberg, Associate Professor of Neurology and Immunology - Harvard Medical School 
Single-Cell and Spatial
  1. Statistical Challenges in Spatial Transcriptomics
    Single-Cell and Spatial
    Rafael Irizarry
    Rafael Irizarry, Professor and Chair - Dana-Farber Cancer Institute, Harvard School of Public Health.
  2. Advancing Tissue Biology Research With Weave Software For Spatial Multi-Omics
    Single-Cell and Spatial
    Marc Claesen
    Marc Claesen, CEO and Co-Founder - Aspect Analytics
  3. Novel Spatial Molecular Pathology Approaches to Understand Disease Pathophysiology and Support Drug Discovery
    Single-Cell and Spatial
    Silvia Siso
    Silvia Siso, Senior Principal Research Scientist - AbbVie
  4. Lunch Break
    Single-Cell and Spatial
  5. High-Throughput Screening of TME Hypotheses for Disease States Using scRNA-seq and Spatial Data
    Single-Cell and Spatial
    Dean Lee
    Dean Lee, Senior Expert I, Data Science - Novartis
  6. Single-Cell and Spatial Transcriptomic Analysis to Understand Metastatic Progression in Ovarian Cancer
    Single-Cell and Spatial
    Kristin Beaumont
    Kristin Beaumont, Associate Professor & Associate Director, Center for Advanced Genomic Technology - Ichan School of Medicine at Mount Sinai
  7. PANEL: How to Integrate Single-Cell and Spatial Effectively? A Deep-Dive into Challenges and Innovations
    Single-Cell and Spatial
    Rebecca Mathew
    Rebecca Mathew, Senior Principal Scientist - Merck
    Arpita Kulkarni
    Arpita Kulkarni, Associate Director - Harvard Medical School 
    Priya Chockalingam
    Priya Chockalingam, Vice President, Head of Clinical Bioanalytics & Translational Sciences - Beam Therapeutics
    Vineeth Raghuram
    Vineeth Raghuram, Senior Scientist I - AbbVie
Genome Dome
  1. Workshop: Common Fund Data Ecosystem as a Resource of Resources: integrating data across multi-modal biomedical resources
    Genome Dome
    Noël Burtt
    Noël Burtt, Director, Operations & Development, Diabetes Research & Knowledge Portals in Medical and Population Genetics Program and Metabolism Program - The Broad Institute
    Jason Flannick
    Jason Flannick, assistant professor of pediatrics - Harvard Medical School and the Division of Genetics and Genomics at Boston Children’s Hospital, associate member of the Broad Institute of MIT
    Ari Kahn
    Ari Kahn, Human Translational Genomics Coordinator Life Sciences Computing Group - TACC
  2. Boston Women in Bioinformatics Networking Session
    Genome Dome
    Lina Faller
    Lina Faller, Associate Director of Bioinformatics and Data Engineering - Korro Bio
  3. Roundtable Discussion: Exploring the Future of Genomic Sequencing: Innovations and Impact
    Genome Dome
    Josh Fienman
    Josh Fienman, Senior Scientist, Genomics (Systems Immunology) - Pfizer
    Midhat Farooqi
    Midhat Farooqi, Director, Molecular Oncology and Professor of Pathology - University of Missouri-Kansas City School of Medicine
    Miten Jain
    Miten Jain, Assistant Professor - Northeastern University
Room 50
  1. Workshop: Enhancing Variant Analysis and Interpretation
    Room 50
    Liz Worthey
    Liz Worthey, Section Head, Director, and Associate Professor, UAB SOM dept of Genetics - UAB School of Medicine
    Suganthi Balasubramanian
    Suganthi Balasubramanian, Director, Computational Biology - Regeneron
    Heidi Rehm
    Heidi Rehm, Co-Director, Medical and Population Genetics & Chief Genomics Officer - Broad Institute
  2. Lunch Break
    Room 50
  3. Workshop: How to Better Computationally Analyze Your Single-Cell RNA Sequencing (scRNA-seq) Data
    Room 50
    Gracie Gordon
    Gracie Gordon, Computational Scientist 3 - Genentech
    Mary Piper
    Mary Piper, Senior Principal Computational Biologist - Pfizer
    Zhaleh Safikhani
    Zhaleh Safikhani, Principal Machine Learning Research Scientist - AbbVie
    Meeta Mistry
    Meeta Mistry, Associate Director - Harvard Chan Bioinformatics Core
Room 51
  1. Workshop: Crafting a Standout CV for U.S. Life Sciences Careers
    Room 51
    Laura L. Stark
    Laura L. Stark, Associate Director for Academic Careers - Harvard University
  2. Roundtable Discussion: Driving Innovation in Precision Medicine for Broader Implementation
    Room 51
    Simon Heeke
    Simon Heeke, Assistant Professor, Thoracic Head & Neck Medical Oncology - MD Anderson Cancer Center
    Winston Hide
    Winston Hide, Director of the Precision RNA Medicine Core - BIDMC
    Kazimierz Wrzeszczynski
    Kazimierz Wrzeszczynski, Associate Director, Clinical Genomics & Molecular Diagnostics - NYU Langone
    Jan Heng
    Jan Heng, Assistant Professor of Pathology, and Director, Detection Unit, Precision RNA Medicine Core - Harvard Medical School and BIDMC

Countdown To The Festival


 

Search